Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,890.00
Bid: 3,820.00
Ask: 3,870.00
Change: 0.00 (0.00%)
Spread: 50.00 (1.309%)
Open: 3,860.00
High: 3,890.00
Low: 3,820.00
Prev. Close: 3,890.00
NAS Live PriceLast checked at -
North Atlantic Smaller Companies is an Investment Trust

To provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

18 Jun 2013 15:01

RNS Number : 3195H
North Atlantic Smlr Co Inv Tst PLC
18 June 2013
 



NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

INTERIM MANAGEMENT STATEMENT FOR THE PERIOD ENDED 31 MAY 2013

 

To the members of North Atlantic Smaller Companies Investment Trust PLC

This interim management statement has been produced solely to provide additional information to shareholders as a body in accordance with the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 February 2013 to 31 May 2013, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

Investment Objective

The objective of North Atlantic Smaller Companies Investment Trust PLC ("the Company") is to provide capital appreciation through investment in a portfolio of smaller companies principally based in countries bordering the North Atlantic Ocean.

 

Financial Highlights

Cumulative performance

As at

31 May 2013

3 months %

6 months %

1 year %

3 years %

5 years %

Diluted NAV*

1,749p

1.6

8.7

22.7

43.5

50.0

Mid-market price

1,440p 

3.3

17.6

55.7

70.8

41.9

Discount to diluted NAV *

17.7% 

Standard & Poor's 500 Composite Index **

1,073.0

7.4

21.3

26.2

43.2

51.9

Russell 2000 **

647.5

7.8

26.1

30.1

42.3

91.9

FTSE All-Share Index

5,090.8

5.0

15.3

30.1

44.1

35.2

US Dollar/Sterling exchange rate

1.5161

0.1

5.4

1.5

(4.4)

23.5

 

* Following the conversion of the Loan Stock, the performance is shown on the diluted NAV (excluding retained revenue for the period) only. The Board considers that this accurately reflects the underlying performance of the Company.

** Sterling adjusted.

 

 

Material Events and Transactions during the Period

 

During the period under review, the Company's Convertible Unsecured Loan Stock 2013 ("the Loan Stock") was all either converted voluntarily by the Loan Stockholders themselves, or was then compulsorily converted by the Trustee of the Loan Stock and subsequently sold with the proceeds from that sale then being distributed rateably to Stockholders. Following this, the Company no longer has any Loan Stock.

 

There have been no material transactions during the quarter ended 31 May 2013.

 

Transaction in Own Shares

 

There have been no transactions in the Company's own shares during the quarter ended 31 May 2013.

 

 

TEN LARGEST INVESTMENTS AT 31 MAY 2013 Percentage of Portfolio

Gleeson (MJ) Group

UK Listed

11.0

US Treasury Bills

US Treasury Bills

10.5

Oryx International Growth Fund Limited *

UK Listed

9.6

Bionostics Holdings Limited

US Unquoted

8.8

Trident Private Equity Fund III LLP

UK Unquoted

7.8

Hampton Investment Properties Limited

UK Unquoted

5.1

Celsis AG

US Unquoted

4.7

Bioquell

UK Listed

3.4

Guinness Peat Group **

UK Listed

3.4

AssetCo PLC

UK Listed

3.3

% of total portfolio

67.6

 

* incorporated in Guernsey

** incorporated in New Zealand

 

SECTOR ANALYSIS OF INVESTMENTS AT FAIR VALUE AS AT 31 MAY 2013

 

United 

United 

Total 

States 

Kingdom 

Europe 

Investment Companies

10.1

9.6

19.7

Health Care, Equipment & Services

0.2

11.1

11.3

Construction & Materials

11.0

11.0

Treasury Bills

10.5

10.5

Manufacturing

8.8

8.8

Real Estate

7.5

0.4

7.9

General Financials

4.3

4.3

Support Services

1.3

2.6

3.9

Financial Services

3.4

3.4

Industrial Engineering

3.3

3.3

General Industrials

1.2

1.5

2.7

General Retailers

2.7

2.7

Transportation

2.6

2.6

Media

0.5

1.8

2.3

Travel & Leisure

2.1

2.1

Oil & Gas Producers

1.1

0.8

1.9

Technology Hardware & Equipment

1.6

1.6

 

The financial information for the period ended 31 May 2013 contained within this Interim Management Statement has not been audited.

 

By order of the Board

 

 

Bonita Guntrip

Company Secretary

18 June 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMVFRLGFZM
Date   Source Headline
17th Apr 202410:52 amRNSNet Asset Value(s)
12th Apr 20243:48 pmRNSHolding(s) in Company
8th Apr 20249:42 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202412:45 pmRNSTransaction in Own Shares - Replacement
21st Mar 20247:00 amRNSTransaction in Own Shares
20th Mar 20243:55 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSDirector/PDMR Shareholding
19th Feb 202411:07 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSDividend Declaration
15th Feb 20247:00 amRNSNet Asset Value(s)
8th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20249:14 amRNSNew Investment: Crest Foods
5th Feb 20247:00 amRNSTransaction in Own Shares
31st Jan 20247:00 amRNSDirector/PDMR Shareholding
17th Jan 20243:32 pmRNSNet Asset Value(s)
27th Dec 20237:00 amRNSDirector Declaration
19th Dec 20237:00 amRNSNet Asset Value(s)
6th Dec 20237:41 amRNSInvestment Update: Ten Entertainment Group Plc
16th Nov 202312:44 pmRNSNet Asset Value(s)
30th Oct 20232:30 pmRNSTransaction in Own Shares
23rd Oct 20232:10 pmRNSTransaction in Own Shares
16th Oct 202312:19 pmRNSNet Asset Value(s)
12th Oct 20238:43 amRNSReplacement: Private Equity Investment Disposal
12th Oct 20237:00 amRNSPrivate Equity investment disposal
9th Oct 20233:02 pmRNSTransaction in Own Shares
15th Sep 20237:00 amRNSHalf-year Report
14th Sep 20231:43 pmRNSNet Asset Value(s)
31st Aug 20234:40 pmRNSCompany Secretary Change
29th Aug 20233:46 pmRNSTransaction in Own Shares - Replacement
29th Aug 20232:49 pmRNSTransaction in Own Shares
21st Aug 20233:07 pmRNSTransaction in Own Shares
16th Aug 20234:15 pmRNSTransaction in Own Shares
15th Aug 202310:03 amRNSNet Asset Value(s)
14th Aug 20232:09 pmRNSTransaction in Own Shares
8th Aug 20234:30 pmRNSTransaction in Own Shares
7th Aug 20234:28 pmRNSTransaction in Own Shares
25th Jul 202312:52 pmRNSNanoco Group Plc
18th Jul 20233:23 pmRNSNet Asset Value(s)
17th Jul 202312:41 pmRNSPortfolio Update
10th Jul 20239:39 amRNSTransaction in Own Shares
3rd Jul 202310:14 amRNSTransaction in Own Shares
30th Jun 202312:17 pmRNSDirector/PDMR Shareholding
26th Jun 202310:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSResult of AGM
15th Jun 20231:15 pmRNSNet Asset Value(s)
26th May 20235:10 pmRNSDirectorate Change
22nd May 20231:37 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.